AstraZeneca CEO Pascal Soriot said manufacturing of a COVID-19 vaccine being developed by Oxford University is beginning already because "we want to be as fast as possible," reported BBC News.
"Of course, with this decision comes a risk but it's a financial risk and that financial risk is the vaccine doesn't work," he added, "then all the materials, all the vaccines, we've manufactured will be wasted."
Soirot said the company was building a number of supply chains across the world "to support global access at no profit during the pandemic and has so far secured manufacturing capacity for two billion doses of the vaccine."
"Having a vaccine is one thing, but you need to produce it at scale and I can tell you that It is not an easy thing to do," he added.
To read more NewsPoints articles, click here.